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Abstract The interaction between protein phosphatase 1 (PPl) 
and microcystin (MC) was stable in 1 % SDS or 70% formic acid 
indicative of a covalent interaction. Here we isolate the MC-
binding peptide and demonstrate that Cys273 of PPI binds co-
valently to the methyl-dehydroalanine (Mdha) residue of the 
toxin. Mutation of Cys273 to Ala, Ser or Leu abolished covalent 
binding to MC, as did reduction of the Mdha residue of the toxin 
with ethanethiol. The abolition of covalent binding increased the 
ICso for toxin inhibition of PPI by 5- to 20-fold. The covalent 
binding of MC to protein serine/threonine phosphatases explains 
the failure to detect this toxin post-mortem in suspected cases of 
MC poisoning. 
Key words: Protein phosphatase; Microcystin; Protein 
phosphorylation; Signal transduction 
1. Introduction 
The family of protein phosphatases (PP) comprising PPJ. 
PP2A and related enzymes [1,2) dephosphorylate serine, thre-
onine and histidine [3) residues in proteins and are critical to 
the control of many biological processes [I). These protein 
phosphatases are inhibited potently and specifically by a chem-
ically diverse group of naturally occurring toxins that include 
okadaic acid, a polyketide produced by marine dinoflagellates 
and the major cause of diarrhetic shellfish poisoning [4); tauto-
mycin. a structurally related polyketide produced by the soil 
bacterium Streptomyces [5); calyculin A, a phosphorylated po-
Iyketide isolated from the sea sponge Discodermia calyx [6); 
cantharidin. a simple terpenoid produced as a defence com-
pound by meloid blister beetles [7). and microcystins (MCs) [8) 
and nodularins [9), which are cyclic peptides produced by sev-
eral species of cyanobacteria. It seems likely that the remarka-
ble conservation in structure of these protein phosphatases 
throughout all eukaryotes [2). and their vital functions [I). has 
made these enzymes particularly susceptible as targets for the 
evolution of these toxins. 
Although the toxins have diverse primary structures. kinetic 
analyses [5,8) and competition binding studies [7.10.11) suggest 
that they, and the specific heat stable protein inhibitors of PPI 
(inhibitor-I and inhibitor-2 [8)). may share common binding 
sites on protein serinelthreonine phosphatases. Amino acid 
substitutions located towards the C-termini of PPI and PP2A 
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AbbreviatIOns: IC,o. concentration giving 50% mhlbltlOn of enzyme 
actiVity 
decrease their sensitivity to toxins and inhibitor-2 [12.13). but 
the precise binding sites have not yet been identified by direct 
structural analysis. 
Okadaic acid. calyculin A and MC each have an acidic 
group, two potential hydrogen bonding sites and a hydropho-
bic side chain which can be superimposed by aligning molecular 
models of these three toxins, and have been proposed as the 
crucial common features for binding to protein phosphatases 
[14). The importance of these carboxylates is supported by the 
finding that methyl esters of okadaic acid [IS) and MC (eM. 
unpublished) and the mono propyl esters of the glut amyl resi-
due of MC and nodularin [16) do not inhibit protein 
phosphatases. Modifications in the hydrophobic tails of MC 
[16) and okadaic acid [17) also reduce enzyme inhibition. 
The interactions between okadaic acid and PPI [18), and 
between cantharidin and PP2A [7) are reversible, but the inter-
action of MC with PPI and PP2A is stable to gel filtration. 
trichloroacetic acid. or heating at 100°C in 1% SDS [19.20). 
suggesting that MC binds covalently to these phosphatases. 
These findings have been exploited to radiolabel PP catalytic 
subunits using CH)MC-LR (tritiated on the glutamyl and /3-
methylaspartyl residues) [20.21) or [125I)MC_YR (iodinated on 
the tyrosine residue of this MC variant) [19). and to detect these 
after SDS-PAGE and autoradiography. Here we demonstrate 
that Cysm on PPI binds covalently to the methyl-dehydroalan-
ine residue on Me. 
2. Materials and methods 
11 Materlllis 
Microcystin-LR (MC-LR) containmg leucme and arginine at two 
positions in the nng (Fig. I) was purified [8] from Microcystis aerugl-
nasa harvested from Rutland Water (Leicestershire. UK). MC-YR 
(containing tyrosine and argmine at the equivalent positions in the ring) 
was a generous gift from Drs. P. Cruz and W. Carmichael (Wright State 
University. Dayton. OR. USA) or was purchased from CalblOchem. 
Both MCs were quantified by ammo acid analysis [19]. The YI-Isoform 
of human PP I [22] expressed in Escherichia coli and purified [23] by Drs. 
A. Street and D. Alessi in thiS laboratory had a specific activity of 15 
Uimg. PPI was labelled with [125I]MC_YR as in [19]. The enzyme was 
mcubated for 30 min With 0.5% 2-mercaptoethanol pnor to reaction 
'WIth MC to eliminate dime ric forms of PPI which accumulate during 
prolonged storage and which do not bind microcystin. 
2.1. PreparatIOn of iodinated MC- YR 
MC-YR was labelled with Nal"I. freed of unreacted label on a 
Waters C I8 Sep-pak cartridge [19] and chromatographed on a Vydac 
CI8 column developed with a gradient of water/acetonitnle m 0.1 % 
trifiuoroacetlc aCid (TFA). Unlabelled MC-YR was eluted at 35.8% 
acetonitnle (peak A). while two peaks of radIO labelled MC were eluted 
at 36.7% (peak B) and 37.5% (peak C) acetonitrile. respectively. All 
three peaks mhlblted PPI and PP2A With equal potency Fast atom 
bombardment mass spectrometry (performed by Mr. F.B Caudwell. 
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MRC Protein PhosphorylatIOn Umt) revealed that Peak B was mono-
iodinated MC-YR while Peak C, was the dl-lodinated derivative. The 
more stable mono-IOdinated Peak B was used for studies where HPLC 
purification of labelled peptides was reqUired. Ethanethiol-MC-YR 
was labelled with 1251 and freed from unreacted Na l251 on a Waters C I8 
Sep-pak cartridge [19]. 
23 Preparation of 3l P-labelled substrates and protein phosphatase 
assays 
PPI was assayed at 30°C by the dephosphorylation of phosphorylase 
a (\0 ,liM. 106 cpm per nmol) in the presence of 5 mM caffeine as 
described [24]. When studying the inhibition ofPPI by MC, the enzyme 
was assayed for 30 mm at the lowest possible concentratIOn (0.025 
mU/mL 0.05 nM) for reasons discussed in section 4. One unit of activity 
(U) was the amount of enzyme that catalysed the release of I ,umol of 
phosphate from substrate in one minute. 
24 Cieal'uge of t25I]MC-YR-labelled PPI with CNBr and trypslll, 
HPLC punftcatlOn of labelled peptides and amlllo acid sequencing 
PPI (45 ,ul, 3 nmol) was reacted with 1251-labelled MC-YR (6,u1, 
I 7 x 106 cpm/,ul; 3.4 x 106 cpm/nmol) as in [19]. The solutIOn was then 
made 70% m formic aCid and a crystal of CNBr added. The mixture 
was incubated for 16 h at 4°C, then diluted to 55% (v/v) formic aCid 
and chroma to graphed on a Vydac C I8 column developed with a gradi-
ent of water/acetomtnle in 0.1 % TFA. The labelled peptide, eluting at 
49 6% acetonitrile was pooled, dried and redissolved m 40 ,ul of 100% 
methanol and 360 pi of 50 mM Tns-HCI (pH 8.0). Trypsin (4,u1, I 
mg'ml-I) was added. and after incubation for 16 h at 37°C, a further 
4 pi of I mg'mtl trypsin was added. After a further 4 h. the solution 
was made 1% in TFA and the sample chroma to graphed on the Vydac 
CI" column as above. The 1251-labelled peaks were then analysed on an 
Applied Biosystems 470A Sequencer 
25 Slle-dlrected mutagenesis and purijzcation of mutant forms of PPI 
pBS+ vector contammg a cDNA encoding human PPIYI [22] was 
modified by PCR mutagenesIs to give the following mutants; Ser268 to 
Ala. Tyr272 to Phe. CysW to Leu. Cys273 to Ala and Cys27l to Ser. The 
mutants were produced by substitution of the Wild-type HindlII-BglII 
fragment ofpBS+PPlYI encoding amino acids 179-323. With a HindIII-
BglII cleaved PCR fragment contaming the mutation. The mutated 
PCR fragments were created by two step recombinant PCR [25]. In the 
first PCR. two overlapping fragments, termed here A and B were 
prepared usmg the pBS+PPIYI plasmid as template. Fragment A was 
amplified with outer forward pnmer (5'-GTCACTCTGTTTGCCGC-
GCCCAAT-3') covenng a unique BglII site and an mner reverse 
pnmer. Fragment B was amplified with an mner forward primer and 
an outer pnmer (5'-CAGTGAGACAAACGGCGCGGGTTA-3') cov-
enng a umque HindIlI site (m the pBS+ hnker). The mner forward and 
reverse primers. used to generate the individual mutations. were: 
(a) Ser268 to Ala. 5'-GCCCAATTATTCCGGAGAGTTTG-3' and 5'-
CAAACTCTCCGGAATAATTGGGC-3'; (b) Tyr2'2 to Phe. 5'-
GCGCCCAATTTTTGCGGAGAGTTT3' and 5'-CAAACTCTCCG-
CAAAAATTGGGCG-3'; (c) Cys2-J to Leu, 5'-GCCCAATATCTC-
GGAGAGTTTG-3' and 5'-CAAACTCTCCGAGATAATTG-
GGC-3'; (d) Cys273 to Ala. 5'-GCCCAATTATGCCGGAGAGTTTG-
3' and 5'-CAAACTCTCCGGCATAATTGGGC-3' and (e) Cys273 to 
Ser. 5'-GCCCAATTATTCCGGAGAGTTTG-3' and 5'-CAAACTC-
TCCGGAATAATTGGGC-3' The reactions (0.1 ml) contamed 20 
mM Tns- HCI pH 8.4. 50 mM KCl. 1.5 mM MgCI2. 0.4 mM of each 
deoxynucleoslde tnphosphate. 50 pmol of each of the appropnate pairs 
of oligonucleotides. 10 ng ofpBS+PPIYI as template. and 5 umts of Taq 
polymerase (Cetus). ConditIOns were: 94°C for 4 mm to denature the 
DNA: followed by 25 cycles of 55°C for I mm. 72°C for 2 mm and 94° C 
for I mm. then 55°C for 2 min; and 72°C for 20 mm. The reactIOns were 
extracted with an equal volume of phenol/chloroform (\ . L by vol), 
followed by chloroform extractIOn and the DNA was punfied by gel 
electrophoresIs Smgle ethidium bromide stained fragments of the ex-
pected size were excised from a 2% gel and punfied usmg a Mermaid 
kit (Stratech. Luton. UK). Fragments A and B were annealed and used 
as a tempLlte (\0 ng) for second-round PCR amplificatIOn With the 
outer forward and reverse pnmers under the same conditIOns used for 
the amplificatIOn at the first round. The reactions were extracted as 
before and precIpItated WIth ethanol. The DNA was dIgested WIth 
HindlII and BgIIL eXCIsed after electrophoresIS on a I % geL purified 
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using Geneclean (Stratech. Luton. UK) and subcloned mto the 
pBS+PPIy construct cleaved previously With HindIlI and BglII to re-
move the corresponding wild-type HindIII-BglII fragment. The se-
quences of the PPIYI mutants were checked on an Applied Biosystems 
373A DNA sequencer using specific oligonucleotide primers. 
The mutant PPIYI DNAs were expressed by subclomng from the 
pBS+ vector into the pCW vector using unique Ndel and HindIII sites. 
The pCW PPIYI plasmlds were transformed mto E coli. DH5a and the 
mutant proteins expressed as described previously [23] 
3. Results 
3.1. Identification oj a specific [ 1251] Me- YR labelled peptide 
from PPI 
The complex formed by incubating [125I]MC_ YR for 2 h with 
PPIYI ran on SDS-PAGE as a radioactive band of 38 kDa, 
equivalent to the molecular mass ofPPIYI (37 kDa) plus toxin 
(1 kDa) [19]. No PPIYI-MC complex was formed if the 
phosphatases were denatured in 1% SDS prior to the addition 
of Me. After cleavage with CNBr and SDS-PAGE of the 
toxin-enzyme complex. a single radio labelled band was seen 
with an apparent molecular mass of II kDa (10 kDa + I kDa 
for the toxin), pinpointing the toxin binding site to a 10.15 kDa 
CNBr peptide which lies towards the C-terminus of PPI. The 
N-terminal sequence of this peptide was found to be 
RPTDVPDQGLL. establishing that it represents the peptide 
comprising residues 191 to 282 [22]. 
The PP1 catalytic SUbUllit was radiolabelled with C25I]MC-
Leu 
Fig. I. Model for the mteractlOn ofPPI with microcystin. Cys273 ofPPl 
binds covalently to the methyl-dehydroalanme reSidue of MC, and the 
ADDA mOiety and the glutamyl carboxylate group of MC are also 
cntical for inhibition of PPI. 
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Fig. 2. PurificatIOn of microcystin-binding peptldes from PPly. (a) 
[12511MC-YR-labelled PPly was digested with CNBr and chromatogra-
phed on a Vydac CI8 column (section 2.4). The acetonitnle gradient is 
shown by the broken line FractIOns of 0.5 ml were collected and 
counted for 1251 radioactlVlty. Peak I, eluting at 36.7% acetonltnle, is 
unreacted [12511MC-YR, while peak 2, eluting at 49.6% acetonltnle, is 
the F2sI1MC-YR-labelled peptide. (b) Peak 2 from (a) was digested with 
trypsm (sectIOn 2.4) and re-chromatographed on the Vydac C 18 column 
as in (a) to generate peptides T1 and T2. 
YR, digested with CNBr and chromatographed on a CIS col-
umn. The minor peak (peptide 1) eluting at 36.7% acetonitrile 
was free [125I]MC_YR, while the major peak (peptide 2) eluting 
at 49.6% acetonitrile was the peptide-MC complex (Fig. 2). 
Peptide 2 was pooled, digested with trypsin and rechromatogra-
phed on the CI8 column. Two radio labelled peaks were ob-
tained eluting at 37.2% (Tl) and 40.3% (T2) acetonitrile and 
their N-terminal sequences were SAPNYCGEFDNAGA and 
XXVTLFSAPNYCGE, respectively (where X represents a res-
idue which could not be assigned unambiguously). These re-
sults demonstrated that peptides Tl and T2 commenced at 
residues 268 and 262 of PPI, respectively, and that TI was 
derived from T2 by a chymotryptic-like cleavage of the Phe-Ser 
bond between residues 267 and 268. 
Peptides Tl and T2 were subjected to solid phase sequencing 
to locate the residue which had bound to [125I]Me. However, 
this proved to be impossible because opening of the MC ring 
during Edman degradation led to the sequencing of the 
[ 125I]MC molecule itself, resulting in the release of 1251 radioac-
tivity at the third cycle for both peptides Tl and T2. Site-
directed mutagenesis was therefore adopted to identify the resi-
due which binds to Me. 
3.2. Site-directed mutagenesis of P P 1 
Peptide Tl, comprising residues 268 to 282, contains only 
three residues (Ser268, Tyr272, Cys273 that have the potential to 
R W MacKintosh et al./FEBS Letters 371 (1995) 236-240 
form a covalent bond and which are conserved among all pro-
tein phosphatases known to be potently inhibited by Me. 
These three residues were therefore mutated to amino acids 
with side chains unable to form a covalent bond. Mutation of 
Ser268 to Ala or Tyr272 to Phe had no effect on the inhibition 
of PPI by MC (Table I) and the toxin still bound covalently 
to the enzyme (Fig. 3). However, mutation ofCys273 to Leu, Ala 
or Ser increased the IC50 for toxin lO-fold or more (Table I) and 
abolished covalent binding (Fig. 3). All the PPI mutants 
showed a sensitivity to inhibitor-2 similar to that of the wild-
type enzyme (Table I). 
3.3. The ethanethiol derivative oj MC- YR does not bind 
covalently to PPl 
A likely mechanism for covalent binding ofMC to Cys273 was 
Michael addition to the methyl-dehydroalanine (Mdha) residue 
of MC [19]. Consistent with this mechanism, ethanethiol addi-
tion to the Mdha residue of MC-YR prevented covalent bind-
ing to PPI as judged by SDS-PAGE and autoradiography (Fig. 
3). The loss of covalent binding was accompanied by a fivefold 
increase in the ICso for inhibition of wild-type PPI without a 
significant difference in the IC50 for inhibition of the Leu273 
mutant (Table I). 
4. Discussion 
MC-YR labelled with 1251 was used previously as an affinity 
tag to identify protein phosphatase catalytic subunits after 
SDS-PAGE. Here. the C251]MC probe has been exploited to 
identify Cys273 of PPIYI as the residue which binds covalently 
to the toxin. The sequence SAPNYC, including Cysm, is con-
served in virtually all known members of the PPl/PP2A family 
[26], and C251]MC should therefore be a useful affinity tag for 
many protem serine/threonine phosphatases; indeed, we have 
shown that it binds covalently to PP2A. An exception is the 
Ca2+/calmodulin-dependent protein phosphatase PP2B (also 
termed calcineurin) which contains Leu in place of Cys and fails 
to bind C25I]MC covalently (R.W.M., unpublished results). 
Table I 
Inhibition of wild-type and mutant forms of the protein phosphatase-l 
catalytIC subunit by MC and inhibitor 2 
Form of PPI IC50 (nM) With ~~~-------------------
Wild type 
Ser268 to Ala 
Tyr27C to Phe 
Cysm to Ala 
Cys27l to Leu 
Cys27l to Ser 
Form ofPPI 
Wild type 
Cysm to Leu 
MC-LR 
0.2 
0.1 
0.2 
4.0 
4.0 
2.2 
IC50 (nM) with 
MC-YR 
0.2 
3.0 
Inhibitor-2 
1.2 
1.0 
3.0 
4.5 
2.0 
3.0 
ET-MC-YR 
0.9 
4.0 
The concentratIOn of PPI m each assay was 0.05 nM. ICso is the 
concentratIOn required for 50% inhIbitIOn. EthanethlOl-MC-YR (ET-
MC-YR) was prepared as descnbed for ammoethanethlOl-MC-LR [191. 
The derivatlzed toxin was chromatographed on a Vydac CIS column as 
in section 2.2 and the peak of ethanethiol-MC-YR eluting at 37.2% 
acetonitrile (and which comprised 95% of the material) was collected, 
dried and redissolved in 10% methanol to gIve a concentration of I mM. 
R W MacKintosh et aU FEBS Letters 371 (1995) 236~240 
(8) 
1 2 3 4 5 6 7 8 9 10 
38kDa-t~" 
~,-.-, .... 
(b) 
1 2 3 4 5 6 7 8 9 10 
38 kDa-
FIg, 3. Covalent bInding of[125I]MC_ YR to wIld-type and mutant forms 
of PP-Iy. (a) Samples of PPly (10 I-lg) were incubated for 2 h wIth 
[125I]MC_ YR as in [19]. then denatured In SDS and subjected to electro-
phoresis on a 12% SDS polyacrylamide gel. and auto radIOgraphed to 
reveal the MC-YR-PPI covalent complex (38 kDa), Lanes I, 3, 5, 7 and 
9, wIld-type PPI; lane 2. PPI Cys271 to Ala; lane 4, PPI Cys273 to Leu; 
lane 6, PPI Ser26' to Ala; lane 8, PPI Tyrm to Phe; lane 10, PPI Cys273 
to Ser. (b) The expenment was carried out as In (a), except that 
[125I]ethanethiol-MC-YR (ET-Me) was used instead of [125I]MC_YR 
(MC) where IndICated, Lane I, WIld-type PPI labelled with MC; lane 
2. wild-type PPI WIth ET-MC; lane 3, PPI Cys273 to Ala with Me. lane 
4, PPI Cys271 to Ala WIth ET-MC; lane 5, PPI Cysm to Leu with MC; 
lane 6. PPI Cys271 to Leu WIth ET-MC; lane 7, PPI Ser268 to Ala with 
Me. lane 8. PPI Ser268 to Ala with ET-MC, lane 9, PPI Tyr272 to Phe 
WIth Me. lane 10. PPI Tyr272 to Phe with ET-Me. 
MC binds to PPI with extremely high affinity and the con-
centration required for 50% inhibition (ICso) is similar to the 
concentration of PPI in the assays, indicating a stoichiometric 
interaction, For this reason the ICso value overestimates the 
true K, value [8]. In the present work, the effects of MC on PPI 
activity were carried out at the lowest possible enzyme concen-
tration (0.05 nM) but, even so, the ICso for inhibition of wild-
type PPI by unmodified MC (0.1-0.2 nM, Table I) was still 
similar to the PPI concentration. The observed 10- to 20-fold 
increase in the ICs]} values for inhibition of the Cys273-mutants 
by Me. and the 4- to 5-fold increase in the ICso value for 
inhibition of Wild-type PPI by ethanethiol-modified-MC, are 
therefore likely to underestimate the decrease m affinity result-
ing from loss of interaction with Cys271. If the assays were 
carned out at the usual PPJ concentrations, which are 10- to 
20-fold higher. almost no difference in the ICso values for inhi-
bition by MC could be detected after mutation of Cys271. This 
may explain the failure of another laboratory to detect any 
change in inhibition by MC when CysC73 ofPPla was mutated 
to Ser [271. 
Taken together, all the available data relating to modifica-
tions of M C supports and extends a model proposed earlier for 
the structure of the toxin binding pocket on protein 
phosphatases [14]. According to this model, binding of the 
toxin and resultant inhibition of the protein phosphatase occurs 
through interaction of the hydrophobic ADDA side-chain and 
the glutamyl carboxyl of Me. Modification of either of these 
groups abolishes inhibition. The results presented in this paper 
lead us to propose that a further interaction IS important, 
namely the covalent linkage of the Mhda residue of MC to 
Cysw (Fig. 1). The double bond of Mdha is chemically the only 
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group of MC to which cysteme could link by a Michael-type 
addition, and its reduction with ethanethiol abolished covalent 
binding to PPJ. There are many naturally occurring toxic mi-
crocystins in which a variety of residues replace the leucine 
and/or the arginine in the peptide ring (Fig. I), indicating that 
these residues are not critical for the inhibition of PPI, In 
summary. the generation of toxin-insensitive phosphatases may 
require the mutation of Cysm, as well the residues that coordi-
nate with the glutamyl carboxylate and the ADDA chain. 
We have previously described an MC-affinity matrix which 
is exceptionally useful for the purification of different forms of 
PPI from mammalian tissues [19,28]. In this matrix, ami-
noethanethiol is added to reduce the Mdha residue before cou-
pling to NHS-activated CH-Sepharose. The present results not 
only explain why this matrix still binds PPI with high affinity. 
but also why PPJ can be recovered from the matrix in an active 
form after elution with high concentrations of chaotropic 
agents. 
MC is a potent hepatotoxin and liver carcinogen [29], which 
has become a potential threat to the health of man and his 
domestic livestock worldwide, because the cyanobacteria which 
produce it are found in many reservoirs. and because their 
growth has increased in recent years due to the enrichment of 
lakes with nitrates from fertilisers used in modern agnculture 
and with phosphates from detergents. The finding of a covalent 
linkage between PPI and the Mdha residue of MC is therefore 
additionally important because it explains why free toxin can-
not be found in postmortem samples from animals that have 
died from suspected MC poisoning (personal communications 
from George Gunn, Scottish Agricultural College, Inverness 
and Wayne Carmichel, Wright State University, Dayton, OH. 
USA). 
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